Xtl Biopharmaceuticals (XTLB) Accounts Payables (2009 - 2025)
Xtl Biopharmaceuticals (XTLB) posted Accounts Payables of $151,000 for the quarter ended Dec 31, 2025, down 80.9% from $790,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Accounts Payables (2009 - 2025) Analysis & Trends
Since the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals has reported Accounts Payables for 47 quarters.
- Annual Accounts Payables shows a five-year compound annual growth rate of -9.9% (years ended Dec 2020 to Dec 2025).
- In prior years, Xtl Biopharmaceuticals' Accounts Payables was $790,000 in the year ended Dec 31, 2024 (+283.5%), $206,000 in the year ended Dec 31, 2023 (+10.2%), $187,000 in the year ended Dec 31, 2022 (-19.0%) and $231,000 in the year ended Dec 31, 2021 (-9.1%).
- The figure for the quarter ended Dec 31, 2025 stands as the lowest quarterly Accounts Payables since the quarter ended Dec 31, 2016.
- On a year-over-year basis, Accounts Payables increased in four of the last six quarters, with growth averaging 120.8%.
- The strongest year-over-year quarter for Accounts Payables in the past five years was the quarter ended Jun 30, 2025, with growth of 286.7%; the weakest was the quarter ended Dec 31, 2025, with a decline of 80.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Xtl Biopharmaceuticals | 2.09 Bn | 2.09 Bn | - | 151,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 151,000.00 |
| Jun 30, 2025 | 638,000.00 |
| Dec 31, 2024 | 790,000.00 |
| Sep 30, 2024 | 554,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | 223,000.00 |
| Dec 31, 2023 | 206,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 163,000.00 |
| Mar 31, 2023 | 241,000.00 |
| Dec 31, 2022 | 187,000.00 |
| Sep 30, 2022 | 153,000.00 |
| Jun 30, 2022 | 172,000.00 |
| Dec 31, 2021 | 231,000.00 |
| Jun 30, 2021 | 258,000.00 |
| Dec 31, 2020 | 254,000.00 |
| Dec 31, 2019 | 232,000.00 |
| Dec 31, 2018 | 253,000.00 |
| Dec 31, 2017 | 300,000.00 |
| Dec 31, 2016 | 17,000.00 |
API Access
Xtl Biopharmaceuticals Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();